Provided by Tiger Trade Technology Pte. Ltd.

BrainStorm Cell Therapeutics Inc.

0.7500
+0.02904.02%
Volume:5K
Turnover:3.38K
Market Cap:8.28M
PE:-0.82
High:0.7900
Open:0.7500
Low:0.7200
Close:0.7210
52wk High:1.33
52wk Low:0.4589
Shares:11.03M
Float Shares:10.28M
Volume Ratio:0.30
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9165
EPS(LYR):-2.3145
ROE:-1121.89%
ROA:-435.92%
PB:-0.83
PE(LYR):-0.32

Loading ...

BrainStorm Cell Therapeutics appoints former FDA official Peter Pitts to board

Reuters
·
May 28

Brainstorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors

THOMSON REUTERS
·
May 28

Press Release: BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market

Dow Jones
·
May 19

Brainstorm Cell Q1 EPS $(0.19) Beats $(0.36) Estimate

Benzinga
·
May 16

BrainStorm Q1 FY26 net loss narrows to $2.13 million; loss per share improves to $0.19

Reuters
·
May 16

Press Release: BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 16

Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate

Benzinga
·
Apr 01

BrainStorm FY25 net loss narrows to $10.3 million

Reuters
·
Apr 01

Press Release: BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 01

Top News Today/Canada: Government Records C$5.07 Billion Budget Deficit

Dow Jones
·
Mar 28

Brainstorm Cell Therapeutics Secures $1M Private Placement at $0.60 a Share

Reuters
·
Feb 26

Brainstorm Cell Therapeutics Announces $1 Million Private Placement at Premium to Market

Reuters
·
Feb 20

Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market

THOMSON REUTERS
·
Feb 20

Brainstorm Cell Therapeutics Raises $1 Million in Private Placement of Shares and Warrants

Reuters
·
Feb 14

Brainstorm Cell Therapeutics Raises Funds Through Unregistered Note Issuances

Reuters
·
Jan 10